drugset / Trial / NCT00416143

Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

NCT00416143

Phase 2/3 Unknown 60 enrolled Sheba Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

sudden sensorineural hearing loss: * idiopathic in most cases * 5-20/100,000 new cases annually in the U.S * no establishes pathogenesis * treated with oral steroids in most cases * \~50% improvement in hearing levels * bed rest - acceptable treatment, not well investigated

Timeline

Start
2006-06
Primary completion
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 1 mg/kg Oral